Advanced Practice - Annual Conference 2016

Nov 4, 2016 ‐ Nov 7, 2016


SUNA is pleased to provide this specialty CNE package focused on the education needs of the Advanced Practice Nurse. The topics include osteoporosis, kidney stones, coding, prostate cancer and Peyronies’s disease. This package is 5 contact hours which includes 1.25 pharmacology hours and is available to members at the discounted rate of $50.00.

Contact hours are included in package price.

Standard: $100.00
Members: $50.00

Products

Dem Bones: Osteoporosis in Men with Urological Disease

Preview Available

Dem Bones: Osteoporosis in Men with Urological Disease

Nov 5, 2016 1:15pm ‐ Nov 5, 2016 2:15pm

Urology practitioners need to be proactive in the evaluation and management of bone health in our prostate cancer patients on ADT, metastatic prostate cancer, and hypogonadism. A review of the pathophysiology of osteoporosis relating to ADT, hypogonadism and bone metastastes, national guidelines are discussed, appropriate screening with DXA scans or bone scans, interpretation of DXA scans, preventative health measures, exercise, and medications used to treat osteoporosis, osteopenia, and bone metastases are presented.

Contact hours available until 11/7/18.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures:
• Valre Welch, MSN, RN, CPNP - Consultant: Hollister Clinical Advisory Board
• Gina Powley, MSN, ANP-BC - Speakers Bureau: Astellas and Medivation

Speaker Disclosures:
• Leanne Schimke, MSN, FNP-C, CRNP, CUNP - Speakers Bureau: Bayer Xofigo

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Learning Outcome:
At the conclusion of this activity, the learner will be able to identify and treat those men who are at risk for osteoporosis.

Speaker(s):
Standard: $30.00
Members: $20.00

Assessing Metabolic Risks in Kidney Stone Patients

Preview Available

Assessing Metabolic Risks in Kidney Stone Patients

Nov 5, 2016 4:00pm ‐ Nov 5, 2016 5:00pm

The prevalence of kidney stone disease is increasing in both adults and children. Metabolic risk factors are present in most patients affected by stones. Targeted therapy towards the patient’s specific abnormalities has been shown to decrease recurrence. The current burden of stone disease in the United States, the metabolic evaluation and risk assessment in patients, and the recommended nutrition and medication measures for prevention are discussed in this session.

Contact hours available until 11/7/18.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures:
• Valre Welch, MSN, RN, CPNP - Consultant: Hollister Clinical Advisory Board
• Gina Powley, MSN, ANP-BC - Speakers Bureau: Astellas and Medivation

Speaker Disclosures:
There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Learning Outcome:
At the conclusion of thie activity, the learner will be able to better understand and recognize the metabolic risk factors associated with kidney stone disease and develop basic strategies for stone prevention.

Speaker(s):
  • Davis P. Viprakasit, MD, Assistant Professor; Director, Multidisciplinary Kidney Stone Clinic, UNC Health Care
Standard: $30.00
Members: $20.00

ICD-10CM- One Year Out, How Does This Impact Urology Providers

Preview Available

ICD-10CM- One Year Out, How Does This Impact Urology Providers

Nov 6, 2016 1:45pm ‐ Nov 6, 2016 2:45pm

This session sheds light on the ICD-10 change and the impact it has had on urology. How has clinical documentation been affected by the higher level of specificity of ICD-10CM? What are the most important concerns for urology providers including major problems encountered, pitfalls, and most important new codes? This session explores items and issues to consider as we move into other outcomes- based reimbursment models.

Contact hours available until 11/7/18.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures:
• Valre Welch, MSN, RN, CPNP - Consultant: Hollister Clinical Advisory Board
• Gina Powley, MSN, ANP-BC - Speakers Bureau: Astellas and Medivation

Speaker Disclosures:
• Susanne Talebian, CUA, CHBC, CPC-I, CPC, CCS-P, PCS, RMM - Consultant: Healthcare Business Solutions LTD

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Learning Outcome:
At the conclusion of this activity, the learner will be able to identify clinical documentation that requires improvement to clarify the appropriate ICD10CM diagnosis code choice.

Speaker(s):
Standard: $30.00
Members: $20.00

Managing Metastatic Castrate Resistant Prostate Cancer

Preview Available

Managing Metastatic Castrate Resistant Prostate Cancer

Nov 6, 2016 3:00pm ‐ Nov 6, 2016 4:00pm

In the last few years, advances in pharmacotherapy and immunotherapy have given new hope in CRPC, with increases in overall survival. Advanced practice providers and nurses need to have an understanding of these treatments, in what setting they are used, side effects, monitoring indicated, and possible complications. Discussion on how to manage advanced prostate cancer and establish a specialized clinic in your practice, and how to monitor current treatments is presented.

Contact hours available until 11/7/18.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures:
• Valre Welch, MSN, RN, CPNP - Consultant: Hollister Clinical Advisory Board
• Gina Powley, MSN, ANP-BC - Speakers Bureau: Astellas and Medivation

Speaker Disclosures:
• Leanne Schimke, MSN, FNP-C, CRNP, CUNP - Speakers Bureau: Bayer Xofigo

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Learning Outcome:
At the conclusion of this session, the participants will be able to critically assess evidence-based treatment options for castration-resistant prostate cancer, focusing on new and emerging therapies to provide comprehensive care and counsel to patients with metastatic CRPC.

Speaker(s):
Standard: $30.00
Members: $20.00

Learning Curve: Clinical Update on Peyronie's Disease

Preview Available

Learning Curve: Clinical Update on Peyronie's Disease

Nov 6, 2016 4:15pm ‐ Nov 6, 2016 5:15pm

This session provides discussion on updates, new drugs, and best practices for the treatment of Peyronie’s, and review the evidence base for current recommendations. Clinical pearls for addressing the concerns of the man with Peyronie’s disease from the advanced practice perspective are also presented.

Contact hours available until 11/7/18.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures:
• Valre Welch, MSN, RN, CPNP - Consultant: Hollister Clinical Advisory Board
• Gina Powley, MSN, ANP-BC - Speakers Bureau: Astellas and Medivation

Speaker Disclosures:
There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Learning Outcome:
At the conclusion of this activity, the learner will be able to discuss the natural history, current knowledge and recommended evidence-based treatment recommendations for Peyronie's disease

Speaker(s):
Standard: $30.00
Members: $20.00